Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) FCF Margin (2023 - 2025)

Mangoceuticals' FCF Margin history spans 3 years, with the latest figure at 1473.38% for Q3 2025.

  • For Q3 2025, FCF Margin fell 59923.0% year-over-year to 1473.38%; the TTM value through Sep 2025 reached 1264.08%, down 54461.0%, while the annual FY2024 figure was 789.74%, 16733.0% up from the prior year.
  • FCF Margin for Q3 2025 was 1473.38% at Mangoceuticals, down from 747.4% in the prior quarter.
  • Across five years, FCF Margin topped out at 462.94% in Q1 2024 and bottomed at 2081.11% in Q1 2025.
  • The 3-year median for FCF Margin is 966.66% (2024), against an average of 1102.82%.
  • The largest annual shift saw FCF Margin skyrocketed 133589bps in 2024 before it tumbled -161817bps in 2025.
  • A 3-year view of FCF Margin shows it stood at 694.73% in 2023, then tumbled by -54bps to 1073.26% in 2024, then crashed by -37bps to 1473.38% in 2025.
  • Per Business Quant, the three most recent readings for MGRX's FCF Margin are 1473.38% (Q3 2025), 747.4% (Q2 2025), and 2081.11% (Q1 2025).